デフォルト表紙
市場調査レポート
商品コード
1596744

幹細胞製造市場:製品、用途、エンドユーザー別-2025-2030年の世界予測

Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Cell & Tissue Banking Applications, Clinical Application, Research Applications), End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
幹細胞製造市場:製品、用途、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

幹細胞製造市場は、2023年に27億4,000万米ドルと評価され、2024年には30億8,000万米ドルに達すると予測され、CAGR 12.65%で成長し、2030年には63億3,000万米ドルになると予測されています。

幹細胞製造は、研究、治療、臨床応用のための幹細胞の開発、生産、加工を包含します。この領域は、幹細胞による組織再生の可能性から極めて重要であり、がん、糖尿病、神経変性疾患などの疾患に対する有望な解決策を提供します。応用範囲は再生医療、創薬、個別化医療に及び、最終用途市場にはヘルスケア施設、研究所、バイオテクノロジー企業が含まれます。主な成長促進要因は、バイオテクノロジーの進歩、再生医療に対する需要の高まり、支持的な規制の枠組みなどです。さらに、研究開発への投資の増加や技術の進歩により、3Dバイオプリンティングや遺伝子編集技術など、技術革新の新たな道筋が開かれています。しかし、市場成長の課題として、製造コストの高さ、倫理的懸念、規制要件の厳しさがあり、これが普及を制限する可能性があります。現在の市場開拓のチャンスは、コスト効率の高い製造プロセスを開発し、個別化医療や臓器移植への応用を拡大することにあります。企業は、共同パートナーシップや政府からの資金援助を活用して技術革新を促進し、こうした制約を克服することができます。合成生物学とバイオインフォマティクスの急速な進歩は、製品開発戦略の強化にもつながります。幹細胞培養の自動化、品質管理のための人工知能の統合、未利用幹細胞の探索などが、イノベーションの推奨分野です。市場の性質はダイナミックで学際的であり、ゲノミクスや材料科学など他の分野と技術的な重複が大きいことが特徴です。規制状況や倫理的ガイドラインを継続的に監視し、スケーラブルな生産モデルに焦点を当てることが、成長を維持し新たな機会を活用するために不可欠です。世界な協力関係を通じて倫理的・コスト的障壁を克服することに重点を置けば、この分野の拡大をさらに促進することができます。このように、変革的なテクノロジーを推進しながら、こうした問題の解決に注力する企業が、幹細胞製造革命の最前線に立つことになると思われます。

主な市場の統計
基準年[2023] 27億4,000万米ドル
予測年 [2024] 30億8,000万米ドル
予測年[2030] 63億3,000万米ドル
CAGR(%) 12.65%

市場力学:急速に進化する幹細胞製造市場の主要市場インサイトを公開

幹細胞製造市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 幹細胞製品の治療効果に対する意識の高まり
    • 世界の幹細胞研究への投資の増加
    • 新興経済諸国における幹細胞研究に対する有利な規制枠組み
  • 市場抑制要因
    • 幹細胞研究にかかるコストの高さ
  • 市場機会
    • 製薬・バイオテクノロジー分野における研究開発の活発化
    • 幹細胞製造における技術の進歩
  • 市場の課題
    • 製造セットアップにおける技術的限界と社会倫理的問題に対する懸念

ポーターの5つの力幹細胞製造市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、幹細胞製造市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:幹細胞製造市場における外部からの影響の把握

外部マクロ環境要因は、幹細胞製造市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析幹細胞製造市場における競合情勢の把握

幹細胞製造市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス幹細胞製造市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、幹細胞製造市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨幹細胞製造市場における成功への道筋を描く

幹細胞製造市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 幹細胞製品の治療効果に対する認識の高まり
      • 世界中で幹細胞調査への投資が増加
      • 新興経済諸国における幹細胞調査に対する好ましい規制枠組み
    • 抑制要因
      • 幹細胞製造には高額な費用がかかる
    • 機会
      • 製薬およびバイオテクノロジー分野における強力な研究開発活動
      • 幹細胞製造における技術的進歩
    • 課題
      • 製造設備に関わる技術的限界と社会倫理的問題に対する懸念
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 幹細胞製造市場:製品別

  • 消耗品
    • 文化メディア
  • 機器
    • バイオリアクターとインキュベーター
    • 細胞選別装置
  • 幹細胞株
    • 胚性幹細胞
    • 造血幹細胞
    • 誘導多能性幹細胞
    • 間葉系幹細胞
    • 多能性成体前駆幹細胞
    • 神経幹細胞

第7章 幹細胞製造市場:用途別

  • 細胞および組織バンキングアプリケーション
  • 臨床応用
    • 同種幹細胞療法
    • 自己幹細胞療法
  • 調査アプリケーション
    • 医薬品の発見と開発
    • ライフサイエンス調査

第8章 幹細胞製造市場:エンドユーザー別

  • 学術機関、調査機関、委託調査機関
  • 細胞・組織バンク
  • 病院と外科センター
  • 製薬・バイオテクノロジー企業

第9章 南北アメリカの幹細胞製造市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の幹細胞製造市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの幹細胞製造市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • AbbVie Inc.
  • Anterogen Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • CellGenix GmbH
  • Corning Incorporated
  • Danaher Corporation
  • Eppendorf AG
  • Fujifilm Holdings Corporation
  • Getinge AB
  • HiMedia Laboratories
  • JCR Pharmaceuticals Co., Ltd.
  • Lonza Group AG
  • Merck Group
図表

LIST OF FIGURES

  • FIGURE 1. STEM CELL MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. STEM CELL MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. STEM CELL MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. STEM CELL MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STEM CELL MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STEM CELL MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY BIOREACTORS & INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY CELL SORTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY MULTIPOTENT ADULT PROGENITOR STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY NEURAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY CELL & TISSUE BANKING APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY ACADEMIC INSTITUTES, RESEARCH LABORATORIES & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY CELL & TISSUE BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY HOSPITALS & SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL STEM CELL MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. TAIWAN STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. THAILAND STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. VIETNAM STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. FRANCE STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. GERMANY STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. ISRAEL STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 250. ITALY STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. NETHERLANDS STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. NIGERIA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. NORWAY STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. POLAND STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. QATAR STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. RUSSIA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 306. SAUDI ARABIA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 314. SOUTH AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 322. SPAIN STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 323. SPAIN STEM CELL MANUFACTURING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN STEM CELL MANUFACTURING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN STEM CELL MANUFACTURING MARKET SIZE, BY STEM CELL LINES, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN STEM CELL MANUFACTURING MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN STEM CELL MANUFACTURING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN STEM CELL MA
目次
Product Code: MRR-46132FF7A2B4

The Stem Cell Manufacturing Market was valued at USD 2.74 billion in 2023, expected to reach USD 3.08 billion in 2024, and is projected to grow at a CAGR of 12.65%, to USD 6.33 billion by 2030.

Stem cell manufacturing encompasses the development, production, and processing of stem cells for research, therapeutic, and clinical applications. This domain is crucial due to the potential of stem cells to regenerate tissues, offering promising solutions for diseases like cancer, diabetes, and neurodegenerative conditions. The application scope spans regenerative medicine, drug discovery, and personalized medicine, with end-use markets including healthcare facilities, research labs, and biotech firms. Key growth drivers include advances in biotechnology, rising demand for regenerative medicines, and supportive regulatory frameworks. Moreover, increased investments in R&D and technological advancements are unlocking new pathways for innovation, such as 3D bioprinting and gene editing technologies. However, market growth is challenged by high production costs, ethical concerns, and stringent regulatory requirements, which may limit widespread adoption. Current market opportunities lie in developing cost-efficient manufacturing processes and expanding applications in personalized medicine and organ transplantation. Companies can leverage collaborative partnerships and government funding to fuel innovation and overcome these limitations. The rapid progression in synthetic biology and bioinformatics also offers prospects for enhancing product development strategies. Recommended areas of innovation include automation in stem cell cultures, integration of artificial intelligence for quality control, and the exploration of underutilized stem cell types. The nature of the market is dynamic and interdisciplinary, characterized by significant technological overlaps with other fields such as genomics and materials science. Continuous monitoring of regulatory landscapes and ethical guidelines, coupled with a focus on scalable production models, will be critical for sustaining growth and capitalizing on emerging opportunities. Emphasis on overcoming ethical and cost barriers through global collaborations can further catalyze the sector's expansion. As such, firms focusing on solving these issues while pushing forward transformative technologies will likely be at the forefront of the stem cell manufacturing revolution.

KEY MARKET STATISTICS
Base Year [2023] USD 2.74 billion
Estimated Year [2024] USD 3.08 billion
Forecast Year [2030] USD 6.33 billion
CAGR (%) 12.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Stem Cell Manufacturing Market

The Stem Cell Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in awareness on therapeutic potency of stem cell products
    • Increasing investments in stem-cell based research globally
    • Favorable regulatory framework in developing economies for stem cell research
  • Market Restraints
    • High cost involved in stem cell manufacturing
  • Market Opportunities
    • Robust research and development activities in pharmaceutical and biotechnology sector
    • Technological advancements in stem cell manufacturing
  • Market Challenges
    • Concerns over technical limitations involved in manufacturing set-up and socio-ethical issues

Porter's Five Forces: A Strategic Tool for Navigating the Stem Cell Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Stem Cell Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Stem Cell Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Stem Cell Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Stem Cell Manufacturing Market

A detailed market share analysis in the Stem Cell Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Stem Cell Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Stem Cell Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Stem Cell Manufacturing Market

A strategic analysis of the Stem Cell Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stem Cell Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Anterogen Co., Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, CellGenix GmbH, Corning Incorporated, Danaher Corporation, Eppendorf AG, Fujifilm Holdings Corporation, Getinge AB, HiMedia Laboratories, JCR Pharmaceuticals Co., Ltd., Lonza Group AG, and Merck Group.

Market Segmentation & Coverage

This research report categorizes the Stem Cell Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Instruments, and Stem Cell Lines. The Consumables is further studied across Culture Media. The Instruments is further studied across Bioreactors & Incubators and Cell Sorters. The Stem Cell Lines is further studied across Embryonic Stem Cells, Hematopoietic Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells, Multipotent Adult Progenitor Stem Cells, and Neural Stem Cells.
  • Based on Application, market is studied across Cell & Tissue Banking Applications, Clinical Application, and Research Applications. The Clinical Application is further studied across Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy. The Research Applications is further studied across Drug Discovery & Development and Life Science Research.
  • Based on End-User, market is studied across Academic Institutes, Research Laboratories & Contract Research Organizations, Cell & Tissue Banks, Hospitals & Surgical Centers, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in awareness on therapeutic potency of stem cell products
      • 5.1.1.2. Increasing investments in stem-cell based research globally
      • 5.1.1.3. Favorable regulatory framework in developing economies for stem cell research
    • 5.1.2. Restraints
      • 5.1.2.1. High cost involved in stem cell manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust research and development activities in pharmaceutical and biotechnology sector
      • 5.1.3.2. Technological advancements in stem cell manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over technical limitations involved in manufacturing set-up and socio-ethical issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Stem Cell Manufacturing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Culture Media
  • 6.3. Instruments
    • 6.3.1. Bioreactors & Incubators
    • 6.3.2. Cell Sorters
  • 6.4. Stem Cell Lines
    • 6.4.1. Embryonic Stem Cells
    • 6.4.2. Hematopoietic Stem Cells
    • 6.4.3. Induced Pluripotent Stem Cells
    • 6.4.4. Mesenchymal Stem Cells
    • 6.4.5. Multipotent Adult Progenitor Stem Cells
    • 6.4.6. Neural Stem Cells

7. Stem Cell Manufacturing Market, by Application

  • 7.1. Introduction
  • 7.2. Cell & Tissue Banking Applications
  • 7.3. Clinical Application
    • 7.3.1. Allogeneic Stem Cell Therapy
    • 7.3.2. Autologous Stem Cell Therapy
  • 7.4. Research Applications
    • 7.4.1. Drug Discovery & Development
    • 7.4.2. Life Science Research

8. Stem Cell Manufacturing Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic Institutes, Research Laboratories & Contract Research Organizations
  • 8.3. Cell & Tissue Banks
  • 8.4. Hospitals & Surgical Centers
  • 8.5. Pharmaceutical & Biotechnology Companies

9. Americas Stem Cell Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Stem Cell Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Stem Cell Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Anterogen Co., Ltd.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bio-Techne Corporation
  • 6. CellGenix GmbH
  • 7. Corning Incorporated
  • 8. Danaher Corporation
  • 9. Eppendorf AG
  • 10. Fujifilm Holdings Corporation
  • 11. Getinge AB
  • 12. HiMedia Laboratories
  • 13. JCR Pharmaceuticals Co., Ltd.
  • 14. Lonza Group AG
  • 15. Merck Group